Pasithea Therapeutics (KTTA) Shares Outstanding (Weighted Average) (2020 - 2026)

Pasithea Therapeutics' Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $24.3 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 1000.66% year-over-year to $24.3 million; the TTM figure through Mar 2026 stood at $24.3 million (up 1000.66% YoY), while the FY2025 annual figure was $7.0 million, up 541.47% from the prior year.
• Shares Outstanding (Weighted Average) came in at $24.3 million for Q1 2026 at Pasithea Therapeutics, up from $7.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $26.5 million in Q3 2022 to a low of $1.0 million in Q1 2024.
• A 5-year average of $6.5 million and a median of $1.3 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) sank 95.14% in 2023 and soared 1000.66% in 2026, its largest moves.
• Pasithea Therapeutics' Shares Outstanding (Weighted Average) stood at $1.3 million in 2022, then dropped by 2.83% to $1.2 million in 2023, then declined by 10.64% to $1.1 million in 2024, then surged by 541.47% to $7.0 million in 2025, then soared by 246.15% to $24.3 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $24.3 million, $7.0 million, and $2.2 million for Q1 2026, Q4 2025, and Q1 2025 respectively.

Peer Comparison